Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05649_nanopub.RAGA2LK1Rgq9c3xqphs7hcM1V7hf2gZTDXW10bDe84Gps#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05649 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05649 label "NTx-265 [drugbank:DB05649]" assertion.
- drugbank:DB05649 seeAlso DB05649 assertion.
- drugbank:DB05649 description "NTx-265 is a combination of two currently marketed large molecules designed to stimulate the growth and differentiation of neural stem cells in adults who have suffered a stroke â the second leading cause of death worldwide. In May 2006, biotechnology company Stem Cell Therapeutics started a Phase IIa study of NTx-265. It is also investigating use of the compound for neurodegenerative disorders, such as Huntingtonâs disease and Alzheimerâs disease." assertion.
- drugbank:DB05649 identifier "drugbank:DB05649" assertion.
- drugbank:DB05649 title "NTx-265" assertion.
- drugbank:DB05649 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05649 drugbank_vocabulary:drugbank-id "DB05649" assertion.
- drugbank:DB05649 bio2rdf_vocabulary:x-identifiers.org DB05649 assertion.
- drugbank:DB05649 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05649" assertion.
- drugbank:DB05649 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05649 bio2rdf_vocabulary:identifier "DB05649" assertion.